Hologic Inc. closed 22.70% short of its 52-week high of $84.67, which the company reached on August 9th.

Fintel reports that on February 6, 2025, Leerink Partners downgraded their outlook for Hologic (NasdaqGS:HOLX) from Outperform to Market Perform. Analyst Price Forecast Suggests 20.21% Upside As of ...

The company said that its molecular diagnostics revenues rose 7 percent on the strength of its women's health assays and Biotheranostics business.

RBC Capital analyst Conor McNamara lowered the firm’s price target on Hologic (HOLX) to $85 from $88 and keeps a Sector Perform rating on the ...

Madison Keys, who captured her first Grand Slam title last month in Melbourne, has not played since her title-run Down Under.

Hologic, Inc. HOLX reported adjusted earnings per share (EPS) of $1.03 in the first quarter of fiscal 2025, up 5.1% year over year. The metric surpassed the Zacks Consensus Estimate by 0.9%. Find the ...